Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Aventis/Regeneron VEGF Colorectal Cancer Indication Part Of $500 Mil. Deal

Related Content

Avastin To Be Standard Add-On Agent In Colorectal Cancer, Genentech Says

Jun 09 2003

Axokine Obesity Trial Setback Weighs Down Regeneron On Wall Street

Apr 07 2003

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window